home / stock / myok / myok news


MYOK News and Press, MyoKardia Inc. From 03/19/20

Stock Information

Company Name: MyoKardia Inc.
Stock Symbol: MYOK
Market: NASDAQ
Website: myokardia.com

Menu

MYOK MYOK Quote MYOK Short MYOK News MYOK Articles MYOK Message Board
Get MYOK Alerts

News, Short Squeeze, Breakout and More Instantly...

MYOK - Data from MAVERICK-HCM Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy Selected for Virtual Late-Breaker Presentation at the American College of Cardiology's 69th Annual Scientific Session Together with World Congress of Cardiology

BRISBANE, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that the company will be presenting data from its Phase 2 MAVERICK-HCM clinical trial during a late-breaker session at the upcoming American College of Cardiology’s 69 th Annual Scien...

MYOK - Cytokinetics: Multiple Growth Catalysts Ahead In 2020

Today, we will see why Cytokinetics ( CYTK ) can be an attractive pick in 2020. Company overview Cytokinetics is a clinical-stage biotechnology company focused on developing innovative treatment options targeting cardiovascular and neuromuscular diseases caused due to impaired muscle fun...

MYOK - MyoKardia, Inc. (MYOK) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool. MyoKardia, Inc.   (NASDAQ: MYOK) Q4 2019 Earnings Call Feb 27, 2020 , 4:30 p.m. ET Operator Continue reading

MYOK - The Q1 Update: Top TipRanks Stocks For 2020 From Kiplinger

Foreword This article is based on a Kiplinger Investing article aimed to find analysts' top stock picks for 2020 , the author, Maya Sasson, published 12/23/19, used "analyst-tracking data to discover the best of the bunch – stocks that have loads of upside potential from current sh...

MYOK - MyoKardia, Inc. (MYOK) CEO Tassos Gianakakos on Q4 2019 Results - Earnings Call Transcript

MyoKardia, Inc. (MYOK) Q4 2019 Earnings Conference Call February 27, 2020 4:30 P.M. ET Company Participants Michelle Corral - Executive Director of Corporate Communications and Investor Relations Tassos Gianakakos - Chief Executive Officer Jay Edelberg - Senior Vice President, Cl...

MYOK - MyoKardia EPS beats by $0.19

MyoKardia (NASDAQ: MYOK ): Q4 GAAP EPS of -$1.27 beats by $0.19 . More news on: MyoKardia, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

MYOK - MyoKardia Reports Fourth Quarter and Full Year 2019 Financial Results

BRISBANE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the fourth quarter and full year ended December 31, 2019. “MyoKardia achieved significant progress in 2019, advancing our pipeline and regaining global rights t...

MYOK - MyoKardia to Present at 40th Annual Cowen Health Care Conference

BRISBANE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 40 th Annual Cowen Health Care Conference on Monday, March 2 nd  2020 at 1:30 p.m. EST in Boston. A webcast of the pr...

MYOK - MyoKardia to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020

BRISBANE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report fourth quarter and full year 2019 financial and operating results on Thursday, February 27, 2020. Management will host a conference call and live audio webcast to discuss ...

MYOK - MyoKardia (MYOK) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by MyoKardia, Inc. in conjunction with this Read more ...

Previous 10 Next 10